Status:
COMPLETED
Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Crohn Disease
Eligibility:
All Genders
18-65 years
Brief Summary
This is an observational study to determine the prevalence of moderate to severe Crohn's disease (CD) among patients with active CD and to evaluate existing therapeutic trends in a standard clinical p...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Must have a diagnosis of active Crohn's Disease irrespective of severity,
- Must be inadequately controlled with their current therapy and for whom physician
- decides to switch treatment.
- Must be between 18 and 65 years of age, of either sex,
- Must demonstrate willingness to participate in the study by signing the written informed consent.
- Exclusion Criteria
- No specific exclusion criteria will be applied to a participant as long as the participant is eligible for the trial
Exclusion
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01218360
Start Date
November 1 2011
End Date
January 1 2015
Last Update
March 19 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.